Abstract: A glass tube, such as a glass tube for the production of containers for storage of pharmaceutical compositions, facilitates production of pharmaceutical containers with high quality. The glass tube has a relative cross-sectional area deviation defined as QF max - QF min 1.5 ? ? m . QF max - QF min 1.5 ? ? m is less than k*x+t. QFmax is the highest cross-sectional area and QFmin is the lowest cross-sectional area of at least two cross-sections of the glass tube, the cross-sections being spaced apart from each other along a length of the glass tube, and k is 0.0023 m?1, t is less than 0.15 mm2/m and x is QF max + QF min 2 .

Abstract: A lighting device includes a phosphor having the general molecular formula (MA)a(MB)b(MC)c(MD)d(TA)e(TB)f(TC)g(TD)h(TE)i(TF)j(XA)k(XB)l(XC)m(X D)n:E. MA is selected from a group of monovalent metals, MB is selected from a group of divalent metals, MC is selected from a group of trivalent metals, MD is selected from a group of tetravalent metals, TA is selected from a group of monovalent metals, TB is selected from a group of divalent metals, TC is selected from a group of trivalent metals, TD is selected from a group of tetravalent metals, TE is selected from a group of pentavalent elements, TF is selected from a group of hexavalent elements, XA is selected from a group of elements which comprises halogens, XB is selected from a group of elements which comprises O, S and combinations thereof, XC=N and XD=C and E=Eu, Ce, Yb and/or Mn.

Abstract: A method for producing bacteriorhodopsin-containing microcapsules is described, which can be optically activated, having a diameter of less than 50 ?m, preferably less than 10 ?m, comprising an enveloping layer, which protects the bacteriorhodopsin from harmful environmental factors, while at the same time preserving the functionality thereof. In doing so, bacteriorhodopsin is suspended in a first step, in the form of PM/BR patches in an aqueous medium having a pH value ranging from 6-9 in the presence of a water-retaining polymer, and said suspension is spray-dried to form a powder, or is dried in an aliphatic solvent using low steam pressure and subsequent dehydration to form a powder. In a second step, the powder obtained in this way is provided with an envelope, which is substantially completely translucent to light in the visible range and made of a polymer and/or a paraffin having a solidification point ranging between 45° C. and 65° C. and/or a carnauba wax having a melting range of 70-90° C.

Abstract: The invention relates to a method for producing a coating, in regions, on a substrate, said coating being based on a formulation, in the form of an active color-change motif, which contains bacteriorhodopsin color-changing pigment, and to coatings produced using a method of this type and to articles having coatings of this type. Here, the method comprises the following steps: a) printing of the substrate with the formulation, in the form of a motif, containing bacteriorhodopsin color-changing pigment; b) partial drying of the printed substrate; c) optionally repetition of steps a) and/or b); calendering of the printed and partially dried substrate; e) complete drying of the coating.

Abstract: The invention relates to a method for producing a coating, in regions, on a substrate, said coating being based on a formulation, in the form of an active colour-change motif, which contains bacteriorhodopsin colour-changing pigment, and to coatings produced using a method of this type and to articles having coatings of this type. Here, the method comprises the following steps: a) printing of the substrate with the formulation, in the form of a motif, containing bacteriorhodopsin colour-changing pigment; b) partial drying of the printed substrate; c) optionally repetition of steps a) and/or b); calendering of the printed and partially dried substrate; e) complete drying of the coating.

Abstract: A method for producing bacteriorhodopsin-containing microcapsules is described, which can be optically activated, having a diameter of less than 50 ?m, preferably less than 10 ?m, comprising an enveloping layer, which protects the bacteriorhodopsin from harmful environmental factors, while at the same time preserving the functionality thereof. In doing so, bacteriorhodopsin is suspended in a first step, in the form of PM/BR patches in an aqueous medium having a pH value ranging from 6-9 in the presence of a water-retaining polymer, and said suspension is spray-dried to form a powder, or is dried in an aliphatic solvent using low steam pressure and subsequent dehydration to form a powder. In a second step, the powder obtained in this way is provided with an envelope, which is substantially completely translucent to light in the visible range and made of a polymer and/or a paraffin having a solidification point ranging between 45° C. and 65° C. and/or a carnauba wax having a melting range of 70-90° C.

Abstract: Methods for producing heterologous terpenes, terpenoids and/or small molecules in transgenic glandular trichome-bearing plants are provided, as well as the transgenic glandular trichome-bearing plants capable of producing the heterologous terpenes, terpenoids and small molecules. The genetically engineered glandular trichome-bearing plants contain and express one or more genes which encode proteins active in the biosynthetic pathways which produce the terpenes, terpenoids and small molecules. As a result, the essential oil of the transgenic plant is enriched for the heterologous or homologous terpenes, terpenoids and/or small molecules Storage of the essential oil in the glandular trichomes of the plant reduces the volatility and cytotoxic capacity of the heterologous molecules, thereby increasing yield and decreasing damage to the transgenic plant.

Abstract: In one aspect, the present invention provides nucleic acid molecules that each correspond to all or part of a messenger RNA (mRNA) molecule expressed in plant oil gland cells, such as oil gland secretory cells of essential oil plants. In another aspect, the present invention provides nucleic acid molecules that hybridize to one or more of the peppermint oil gland cDNAs disclosed herein (or to the complement of one or more of the peppermint oil gland cDNAs disclosed herein), under stringent conditions. In another aspect, the present invention provides replicable recombinant cloning vehicles comprising a nucleic acid molecule of the present invention. In yet other aspects of the invention, modified host cells are provided that include a recombinant cloning vehicle and/or nucleic acid molecule of the present invention.

Abstract: Disclosed are polynucleotide and polypeptide sequences involved in or associated with isoprenoid biosynthesis in plants. Also disclosed are uses for such sequences.

Abstract: cDNAs encoding 1-deoxyxylulose-5-phosphate synthase from peppermint (Mentha piperita) have been isolated and sequenced, and the corresponding amino acid sequences have been determined. Accordingly, isolated DNA sequences (SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7) are provided which code for the expression of 1-deoxyxylulose-5-phosphate synthase from plants. In another aspect the present invention provides for isolated, recombinant DXPS proteins, such as the proteins having the sequences set forth in SEQ ID NO:4, SEQ ID NO:6 and SEQ ID NO:8. In other aspects, replicable recombinant cloning vehicles are provided which code for plant 1-deoxyxylulose-5-phosphate synthases, or for a base sequence sufficiently complementary to at least a portion of 1-deoxyxylulose-5-phosphate synthase DNA or RNA to enable hybridization therewith.